Sustainable Medicines Manufacturing
The Sustainable Medicines Manufacturing Innovation programme will focus on innovation in pharmaceutical manufacturing to improve the manufacturing innovation ecosystem in the UK towards a sustainable future.
Promoting the long-term viability of the medicines manufacturing industry
Sustainable medicines manufacturing, strives for the production of medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability.
Innovate UK’s Sustainable Medicines Manufacturing programme aims to transform the UK’s medicines manufacturing sector by driving innovation, adoption, investment, and collaboration. The programme will focus on developing disruptive technologies to optimise production efficiency, minimise waste, and reduce emissions, aligning with global sustainability goals. It will promote the adoption of innovative solutions across the sector to ensure scalability and widespread use while enhancing the UK’s attractiveness as a prime location for investment in medicines manufacturing, fostering economic growth and resilience.
By strengthening partnerships among academia, industry, and government, the programme will enhance the UK’s manufacturing innovation ecosystem and promote sustainable practices.
The Sustainable Medicines Manufacturing Innovation programme is funded as part of the wider VPAG Investment Programme agreed as part of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).
Focus areas
PILLAR
Green chemistry
Producing medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability.
PILLAR
Circularity
Reducing waste, energy consumption and emissions, while enhancing efficiency, safety, and cost-effectiveness throughout the manufacturing lifecycle.
PILLAR
Productivity
Adopting of innovative technologies and practices that promote the long-term viability of the medicines manufacturing industry.
Sustainable Medicines Manufacturing collaboration database
We are building a collaboration database for all competitions within the Sustainable Medicines Manufacturing Innovation Programme. To join the directory of organisations, create and share your collaboration profile detailing your needs and offerings with our team. By participating, you can connect with potential partners, with new collaborators being added each month to expand opportunities.
Download database
Related Opportunities
Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest
EOIs accepted on a rolling basis; quarterly assessments
Capital grants to support investments over £8m in the manufacture of human medicines, medical diagnostics and medtech products; assessed quarterly
More Information
Horizon Europe Pump Priming collaboration opportunities 2024
Opens: 12/11/2024 Closes: 17/01/2025
Innovate UK and British Academy are pleased to announce funding schemes for Horizon Europe Pump Priming Grants, open to all disciplines.
More Information
Knowledge Transfer Partnership (KTP): 2024 to 2025 Round 5
Opens: 09/12/2024 Closes: 12/02/2025
UK registered academic institutions, RTOs or Catapults can apply for a share of up to £9m to fund innovation projects with businesses or not for profits.
More Information
Related Events and Recordings
Thu
25
Jul
2024
Sustainable Medicines Manufacturing Innovation Programme Information Webinar
11.00 - 12.00 GMT | Online
Watch now
Tue
11
Feb
2025
Sustainable bio-based Materials and Manufacture (SusBioMM) Cafes
10.00 - 10.45 | Online
Register for this series
Our Experts
SUBSCRIBE
Transforming Medicines Manufacturing Community of Practice
Join our collaborative forum to create a dynamic learning environment that promotes active participation and drives forward cutting-edge innovation in medicines manufacturing.
Read more and subscribe
Related programme
Transforming Medicines Manufacturing
Innovate UK’s Transforming Medicines Manufacturing programme aims to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.